• 1. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 2. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 3. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 4. Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation
  Feng Shi,Kunping Yan,Mingli Peng,Xiao Cheng,Yanling Luo,Xuemei Chen,V. A. L. Roy,Zuankai Wang Nanoscale, 2012,4, 747-751
• 5. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Comprehensive Overview of (S)-2-Amino-3-(4-ethoxyphenyl)propanoic acid (CAS No. 32795-52-1)

(S)-2-Amino-3-(4-ethoxyphenyl)propanoic acid, with the CAS number 32795-52-1, is a specialized amino acid derivative that has garnered significant attention in pharmaceutical and biochemical research. This compound, often referred to as a non-proteinogenic amino acid, is structurally characterized by an ethoxy-substituted phenyl group attached to the alpha-carbon of the amino acid backbone. Its unique structure makes it a valuable intermediate in the synthesis of peptide-based therapeutics and enzyme inhibitors.

The growing interest in (S)-2-Amino-3-(4-ethoxyphenyl)propanoic acid is driven by its potential applications in drug discovery and medicinal chemistry. Researchers are particularly intrigued by its role in modulating biological pathways related to inflammation and metabolic disorders. Recent studies have explored its utility as a chiral building block for designing targeted therapies, aligning with the current trend toward personalized medicine.

One of the most frequently searched questions about CAS 32795-52-1 revolves around its synthesis methods and purity standards. High-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy are commonly employed to ensure the compound's optical purity and structural integrity. These analytical techniques are critical for meeting the stringent requirements of pharmaceutical-grade materials.

In the context of green chemistry, (S)-2-Amino-3-(4-ethoxyphenyl)propanoic acid has also been studied for its potential to reduce synthetic waste. Innovations in catalytic asymmetric synthesis have enabled more efficient production routes, minimizing environmental impact. This aligns with the broader industry shift toward sustainable chemical processes, a topic frequently discussed in academic and industrial forums.

The compound's physicochemical properties, such as solubility and stability, are another area of interest. Its ethoxy group enhances lipophilicity, making it suitable for formulations requiring enhanced membrane permeability. These attributes are particularly relevant in the development of oral bioavailability enhancers, a hot topic in pharmacokinetics research.

From a commercial perspective, 32795-52-1 is often listed by suppliers specializing in fine chemicals and research reagents. Its pricing and availability are influenced by factors like batch size and custom synthesis requirements. For researchers seeking alternatives, derivatives such as (R)-enantiomers or halogen-substituted analogs are also available, expanding the scope of structure-activity relationship studies.

In summary, (S)-2-Amino-3-(4-ethoxyphenyl)propanoic acid (CAS No. 32795-52-1) represents a versatile tool in modern chemistry and drug development. Its applications span from peptide engineering to sustainable synthesis, reflecting the interdisciplinary nature of contemporary scientific inquiry. As demand for high-purity chiral compounds grows, this amino acid derivative is poised to remain a focal point of innovation.

• 18822-59-8((S)-2-Amino-3-(4-(tert-butoxy)phenyl)propanoic acid)
• 33879-32-2(3-Methoxy-L-Phenylalanine)
• 6230-11-1(O-Methyl-L-tyrosine)
• 16652-64-5(O-Benzyl-L-tyrosine)
• 145306-65-6(3-Methoxy-D-phenylalanine)
• 186698-58-8(O-Tert-Butyl-D-tyrosine)
• 39878-65-4((R)-2-Amino-3-(4-methoxyphenyl)propanoic Acid)
• 1596-67-4(L-Thyronine, 95%)
• 1034-10-2(Dl-Thyronine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)